NextGen Ventures Secures €28.5M to Invest in Early-Stage Medtech
The Dutch investment fund NextGen Ventures has announced the first close of its newest fund at €28.5 million, aimed at supporting early-stage medical technology startups. Invest-NLDealroom has a profile for this one. Try Dealroom → has committed €5 million to the fund, signaling the importance of helping innovations reach patients and improve healthcare outcomes.
The fund focuses on a particularly challenging stage of the medtech market. Many promising startups struggle to secure financing for product development and certification, which are often long and costly processes. Traditional investors tend to step in only after international certification or initial commercial revenue, leaving an early-stage gap sometimes called the “Valley of Death,” where innovations risk never reaching patients.
NextGen Ventures has built a reputation for bridging this gap. The fund has previously invested in companies such as ManometricDealroom has a profile for this one. Try Dealroom →, Momo MedicalDealroom has a profile for this one. Try Dealroom →, ShanX Medtech, and AMT Medical, often co-investing alongside other partners. By targeting startups in this early phase, NextGen Ventures aims to provide the capital and support needed to navigate development and regulatory hurdles.
The fund hopes to eventually raise up to €50 million, and if successful, Invest-NL has indicated its commitment may increase.
Source:
Fd.nl
A.M.
